Cargando…
Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy
Immune checkpoint blockade (ICB) therapy has demonstrated good efficacy in many cancer types. In cancers such as non-resectable advanced or metastatic triple-negative breast cancer (TNBC), it has recently been approved as a promising treatment. However, clinical data shows overall response rates (OR...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200712/ https://www.ncbi.nlm.nih.gov/pubmed/35705580 http://dx.doi.org/10.1038/s41598-022-13930-7 |